NicVAX® (Nicotine Conjugate Vaccine) is an investigational vaccine designed as an aid to smoking cessation, as well as an aid to prevent relapses of a treated smoker

NicVAX represents an extension of our conjugate vaccine technology that allows us to address a significant medical need.

We believe that broad commercialization of NicVAX will be in conjunction with a marketing partner that has a demonstrated expertise in executing large scale sales and marketing programs because the physician audience will likely be primary care physicians and focused outside the hospital setting.

Nicotine is a small molecule that upon inhalation into the body quickly passes into the bloodstream and subsequently reaches the brain by crossing the blood-brain barrier. Once in the brain, the nicotine binds to specific nicotine receptors, which results in the release of stimulants, such as dopamine, providing the smoker with a positive sensation, which causes addiction.

NicVAX is designed to stimulate the immune system to produce antibodies that bind to nicotine in the bloodstream and prevent it from crossing the blood-brain barrier and entering the brain. Therefore, the brain does not produce the positive-sensation stimulants as a response to nicotine.

Pre-clinical animal studies with NicVAX have shown that vaccination could prevent nicotine from reaching the brain blocking the effects of nicotine, including effects that can lead to addiction or can reinforce and maintain addiction.

Nicotine addiction is difficult to treat effectively. We believe NicVAX has advantages over existing treatment therapies because its effect is irreversible for potentially six to 12 months following vaccination as antibodies to nicotine continue to be produced by the body?s immune system. This is important due to the extremely high relapse rate that has been observed when a smoker attempts to quit smoking. Currently, smokers being treated for nicotine addiction can stop using their therapy and resume their addiction.

In September 2005, we were awarded a $4.1 million grant by the U.S. National Institute on Drug Abuse, or NIDA, partially offsetting our funding requirements for the NicVAX development program.

Following the award of the NIDA grant, we formed a scientific advisory panel to provide us guidance on clinical trial design and clinical development plans for NicVAX.

Market

Smoking is a global healthcare problem. The WHO estimates that there are 1.3 billion smokers worldwide today and nearly five million tobacco-related deaths each year. If current smoking patterns continue, smoking will cause some 10 million deaths each year by 2020. According to the CDC, tobacco use is the single leading preventable cause of death in the U.S., responsible for approximately 438,000 deaths each year.

In addition, it is estimated that smoking results in an annual health-related economic cost of approximately $157 billion. The CDC estimates that, among the 45 million adult smokers in the U.S., 70% want to quit, but less than five percent of those who try to quit remain smoke-free after 12 months.

Clinical Trials

In February 2006, the U.S. Food and Drug Administration granted Fast Track Status to NicVAX for use as a therapeutic for smoking cessation.

Source: Nabi.Com

Quit Smoking Aid from Amazon..

	NicoDerm CQ STEP 1 - 3 Week Kit - 21 Clear 21 mg Nicotine Patches List Price: $72.99 Sale Price: $51.20
	Getting Started with NicoDerm CQ Preparing to quit is important, take some time to do it right. * Select the NicoDerm CQ that's right for you. If you smoke more than 10 cigarettes per day: start with Step 1, 10 or less cigarettes per day: start with Step 2...

	Nicorette Gum, Original, 2 mg, 170 Count Box List Price: $97.23 Sale Price: $49.12
	Nicotine Polacrilex Gum. For those who smoke less than 25 or more cigarettes a day. If you smoke more than 25 cigarettes a day, use 4mg. Chew activated release.

	NicoDerm CQ Step 3 Clear Patch, 7 mg, 2-Week Kit (14 patches) List Price: $73.27 Sale Price: $30.99
	When you decide to quit smoking, NicoDerm CQ with SmartControl can give you 24-hour defense against cravings. NicoDerm CQ is the only clear patch specially formulated with patented SmartControl technology that helps provide a controlled release of therapeutic nicotine for 24 hours* to help fight cravings all day long...

	Nicorette 4 mg Gum, Fruit Chill, 160 Count List Price: $111.13 Sale Price: $56.12
	Nicorette fruit chill gum helps calm your withdrawal symptoms when you're trying to quit smoking. when you stop smoking, the sudden removal of nicotine from your system lowers your dopamine levels, making you feel moody and irritable.

	Nicorette Coated Gum 4mg, 100 pieces (Fresh Mint) List Price: $73.56 Sale Price: $34.98
	For those who smoke less than 25 cigarettes a day. Each piece contains: calcium (94 mg), sodium (13 mg).

	NicoDerm CQ Step 1 Opaque Patch, 21 mg, 2-Week Kit (14 patches) List Price: $73.27 Sale Price: $31.98
	When you decide to quit smoking, NicoDerm CQ with SmartControl can give you 24-hour defense against cravings. NicoDerm CQ is the only clear patch specially formulated with patented SmartControl technology that helps provide a controlled release of therapeutic nicotine for 24 hours* to help fight cravings all day long...

	Nicorette 2mg Coated Cinnamon Surge 160 Pieces List Price: $129.64 Sale Price: $54.47
	Nicorette cinammon gum helps calm your withdrawal symptoms when you're trying to quit smoking. when you stop smoking, the sudden removal of nicotine from your system lowers your dopamine levels, making you feel moody and irritable.

	Nicorette Coated Gum 2mg, 100 pieces (Fresh Mint) List Price: $73.56 Sale Price: $39.99
	For those who smoke less than 25 cigarettes a day. Each piece contains: calcium (94 mg), sodium (11 mg).